Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of DMPA and High Dose MPA for Acute Uterine Bleeding
NCT01148420Phase 4Completed
- Sponsor
- Women's Health Care Clinic
- Start
- Jan 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of medroxyprogesterone acetate in dysfunctional uterine bleeding (DUB), sponsored by Women's Health Care Clinic. Primary endpoints: Time Elapsed to Slowing Acute Bleeding, Compliance with Study Medications and 1 more. Started Jan 2009; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
dysfunctional uterine bleeding (DUB)
Beyond the preview
Go deeper on NCT01148420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148420.